Oxidative stress, mitochondrial dysfunction and the mitochondria theory of aging

Interdisciplinary Topics in Gerontology

Volumn 39, Issue , 2014, Pages 86-107

  Kong, Yahui ^a   Trabucco, Sally E ^a   Zhang, Hong ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

AGING; ALZHEIMER DISEASE; ANIMAL; CELL AGING; CELL DEATH; GENETICS; HUMAN; HUNTINGTON CHOREA; LONGEVITY; METABOLISM; MITOCHONDRION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; STEM CELL;

AGING; ALZHEIMER DISEASE; ANIMALS; CELL AGING; CELL DEATH; DNA, MITOCHONDRIAL; HUMANS; HUNTINGTON DISEASE; LONGEVITY; MITOCHONDRIA; OXIDATIVE STRESS; PARKINSON DISEASE; REACTIVE OXYGEN SPECIES; STEM CELLS;

EID: 84904624833     PISSN: 00741132     EISSN: 16623800     Source Type: Book Series    
DOI: 10.1159/000358901     Document Type: Article

References (266)

1. Kowaltowski AJ, et al: Mitochondria and reactive oxygen species. Free Radic Biol Med 2009; 47: 333-343.
2. Kirkinezos IG, Moraes CT: Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol 2001; 12: 449-457.
3. Chen SX, Schopfer P: Hydroxyl-radical production in physiological reactions. A novel function of peroxidase. Eur J Biochem 1999; 260: 726-735.
4. Bonekamp NA, et al: Reactive oxygen species and peroxisomes: struggling for balance. Biofactors 2009; 35: 346-355.
5. Bedard K, Krause KH: The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87: 245-313.
6. Hussain SP, Hofseth LJ, Harris CC: Radical causes of cancer. Nat Rev Cancer 2003; 3: 276-285.
7. Ercal N, Gurer-Orhan H, Aykin-Burns N: Toxic metals and oxidative stress. I. Mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem 2001; 1: 529-539.
8. Klaunig JE, Kamendulis LM: The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004; 44: 239-267.
9. Kovacic P, Osuna JA Jr: Mechanisms of anti-cancer agents: emphasis on oxidative stress and electron transfer. Curr Pharm Des 2000; 6: 277-309.
10. Liu J, Qu W, Kadiiska MB: Role of oxidative stress in cadmium toxicity and carcinogenesis. Toxicol Appl Pharmacol 2009; 238: 209-214.
11. McMillan TJ, et al: Cellular effects of long wavelength UV light (UVA) in mammalian cells. J Pharm Pharmacol 2008; 60: 969-976.
12. Norbury CJ, Hickson ID: Cellular responses to DNA damage. Annu Rev Pharmacol Toxicol 2001; 41: 367-401.
13. O'Neill P, Wardman P: Radiation chemistry comes before radiation biology. Int J Radiat Biol 2009; 85: 9-25.
14. Clanton TL: Hypoxia-induced reactive oxygen species formation in skeletal muscle. J Appl Physiol (1985) 2007; 102: 2379-2388.
15. Fang J, Seki T, Maeda H: Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Deliv Rev 2009; 61: 290-302.
16. Ha H, Lee HB: Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology (Carlton) 2005; 10(suppl):S7-S10.
17. Leonard SS, Harris GK, Shi X: Metal-induced oxidative stress and signal transduction. Free Radic Biol Med 2004; 37: 1921-1942.
18. Lushchak VI: Environmentally induced oxidative stress in aquatic animals. Aquat Toxicol 2011; 101: 13-30.
19. Morgan MJ, Liu ZG: Reactive oxygen species in TNFalpha-induced signaling and cell death. Mol Cells 2010; 30: 1-12.
20. Muller I, Niethammer D, Bruchelt G: Anthracyclinederived chemotherapeutics in apoptosis and free radical cytotoxicity. Int J Mol Med 1998; 1: 491-494.
21. Valko M, et al: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
22. Suzuki YJ, Forman HJ, Sevanian A: Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997; 22: 269-285.
23. Finkel T: Signal transduction by reactive oxygen species. J Cell Biol 2011; 194: 7-15.
24. Krause KH: Aging: a revisited theory based on free radicals generated by NOX family NADPH oxidases. Exp Gerontol 2007; 42: 256-262.
25. Brieger K, et al: Reactive oxygen species: from health to disease. Swiss Med Wkly 2012; 142:w13659.
26. Bartz RR, Piantadosi CA: Clinical review: oxygen as a signaling molecule. Crit Care 2010; 14: 234.
27. Marnett LJ: Oxyradicals and DNA damage. Carcinogenesis 2000; 21: 361-370.
28. Cadet J, Wagner JR: DNA base damage by reactive oxygen species, oxidizing agents, and UV radiation. Cold Spring Harb Perspect Biol 2013; 5:a012559.
29. Dizdaroglu M, et al: Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med 2002; 32: 1102-1115.
30. Hulbert AJ, et al: Life and death: metabolic rate, membrane composition, and life span of animals. Physiol Rev 2007; 87: 1175-1213.
31. Pamplona R, Costantini D: Molecular and structural antioxidant defenses against oxidative stress in animals. Am J Physiol Regul Integr Comp Physiol 2011; 301:R843-R863.
32. Sykora P, Wilson DM 3rd, Bohr VA: Repair of persistent strand breaks in the mitochondrial genome. Mech Ageing Dev 2012; 133: 169-175.
33. Jung T, Grune T: The proteasome and its role in the degradation of oxidized proteins. IUBMB Life 2008; 60: 743-752.
34. Pang CY, Ma YS, Wei YU: MtDNA mutations, functional decline and turnover of mitochondria in aging. Front Biosci 2008; 13: 3661-3675.
35. Harman D: Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298-300.
36. Beckman KB, Ames BN: The free radical theory of aging matures. Physiol Rev 1998; 78: 547-581.
37. Sohal RS: Role of oxidative stress and protein oxidation in the aging process. Free Radic Biol Med 2002; 33: 37-44.
38. Linnane AW, et al: Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989; 1: 642-645.
39. Miquel J, et al: Mitochondrial role in cell aging. Exp Gerontol 1980; 15: 575-591.
40. Schlame M, Rua D, Greenberg ML: The biosynthesis and functional role of cardiolipin. Prog Lipid Res 2000; 39: 257-288.
41. Lucas-Sanchez A, et al: Age-related changes in mitochondrial membrane composition of Nothobranchius rachovii . J Gerontol A Biol Sci Med Sci 2014; 69: 142-151.
42. Almaida-Pagan PF, et al: Age-related changes in mitochondrial membrane composition of rainbow trout (Oncorhynchus mykiss) heart and brain. Comp Biochem Physiol B Biochem Mol Biol 2012; 163: 129-137.
43. Yu BP, Suescun EA, Yang SY: Effect of age-related lipid peroxidation on membrane fluidity and phospholipase A2: modulation by dietary restriction. Mech Ageing Dev 1992; 65: 17-33.
44. Hagen TM, et al: Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase. Proc Natl Acad Sci USA 1997; 94: 3064-3069.
45. Pamplona R: Membrane phospholipids, lipoxidative damage and molecular integrity: a causal role in aging and longevity. Biochim Biophys Acta 2008; 1777: 1249-1262.
46. Spiteller G: Lipid peroxidation in aging and age-dependent diseases. Exp Gerontol 2001; 36: 1425-1457.
47. Pamplona R, et al: Modification of the longevity-related degree of fatty acid unsaturation modulates oxidative damage to proteins and mitochondrial DNA in liver and brain. Exp Gerontol 2004; 39: 725-733.
48. Thorpe SR, Baynes JW: Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids 2003; 25: 275-281.
49. Ma YS, et al: Response to the increase of oxidative stress and mutation of mitochondrial DNA in aging. Biochim Biophys Acta 2009; 1790: 1021-1029.
50. Bulteau AL, Szweda LI, Friguet B: Mitochondrial protein oxidation and degradation in response to oxidative stress and aging. Exp Gerontol 2006; 41: 653-657.
51. Berlett BS, Stadtman ER: Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997; 272: 20313-20316.
52. Beinert H, Kiley PJ: Fe-S proteins in sensing and regulatory functions. Curr Opin Chem Biol 1999; 3: 152-157.
53. Veatch JR, et al: Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defect. Cell 2009; 137: 1247-1258.
54. Wei YH, Lee HC: Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp Biol Med (Maywood) 2002; 227: 671-682.
55. Park CB, Larsson NG: Mitochondrial DNA mutations in disease and aging. J Cell Biol 2011; 193: 809-818.
56. Bota DA, Davies KJ: Protein degradation in mitochondria: implications for oxidative stress, aging and disease: a novel etiological classification of mitochondrial proteolytic disorders. Mitochondrion 2001; 1: 33-49.
57. Ugarte N, Petropoulos I, Friguet B: Oxidized mitochondrial protein degradation and repair in aging and oxidative stress. Antioxid Redox Signal 2010; 13: 539-549.
58. Maynard S, et al: Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis 2009; 30: 2-10.
59. Hegde ML, et al: Oxidative genome damage and its repair: implications in aging and neurodegenerative diseases. Mech Ageing Dev 2012; 133: 157-168.
60. Stuart JA, Brown MF: Mitochondrial DNA maintenance and bioenergetics. Biochim Biophys Acta 2006; 1757: 79-89.
61. Druzhyna NM, Wilson GL, LeDoux SP: Mitochondrial DNA repair in aging and disease. Mech Ageing Dev 2008; 129: 383-390.
62. Lemasters JJ: Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res 2005; 8: 3-5.
63. Green DR, Galluzzi L, Kroemer G: Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 2011; 333: 1109-1112.
64. Baker MJ, Tatsuta T, Langer T: Quality control of mitochondrial proteostasis. Cold Spring Harb Perspect Biol 2011; 3:a007559.
65. Batlevi Y, La Spada AR: Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging. Neurobiol Dis 2011; 43: 46-51.
66. Pamplona R, Barja G: Highly resistant macromolecular components and low rate of generation of endogenous damage: two key traits of longevity. Ageing Res Rev 2007; 6: 189-210.
67. Pamplona R, Barja G, Portero-Otin M: Membrane fatty acid unsaturation, protection against oxidative stress, and maximum life span: a homeoviscous-longevity adaptation? Ann NY Acad Sci 2002; 959: 475-490.
68. Sanz A, Pamplona R, Barja G: Is the mitochondrial free radical theory of aging intact? Antioxid Redox Signal 2006; 8: 582-599.
69. Hwang AB, Jeong DE, Lee SJ: Mitochondria and organismal longevity. Curr Genomics 2012; 13: 519-532.
70. Kirchman PA, et al: Interorganelle signaling is a determinant of longevity in Saccharomyces cerevisiae . Genetics 1999; 152: 179-190.
71. Feng J, Bussiere F, Hekimi S: Mitochondrial electron transport is a key determinant of life span in Caenorhabditis elegans . Dev Cell 2001; 1: 633-644.
72. Lee SS, et al: A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat Genet 2003; 33: 40-48.
73. Liu X, et al: Evolutionary conservation of the clk- 1-dependent mechanism of longevity: loss of mclk1 increases cellular fitness and lifespan in mice. Genes Dev 2005; 19: 2424-2434.
74. Dell'agnello C, et al: Increased longevity and refractoriness to Ca 2+ -dependent neurodegeneration in Surf1 knockout mice. Hum Mol Genet 2007; 16: 431-444.
75. Copeland JM, et al: Extension of Drosophila life span by RNAi of the mitochondrial respiratory chain. Curr Biol 2009; 19: 1591-1598.
76. Yang W, Hekimi S: Two modes of mitochondrial dysfunction lead independently to lifespan extension in Caenorhabditis elegans . Aging Cell 2010; 9: 433-447.
77. Dillin A, et al: Rates of behavior and aging specified by mitochondrial function during development. Science 2002; 298: 2398-2401.
78. Braeckman BP, et al: Apparent uncoupling of energy production and consumption in long-lived Clk mutants of Caenorhabditis elegans . Curr Biol 1999; 9: 493-496.
79. Trifunovic A, et al: Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004; 429: 417-423.
80. Kujoth GC, et al: Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005; 309: 481-484.
81. Vermulst M, et al: DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice. Nat Genet 2008; 40: 392-394.
82. Xie Y, et al: Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon12 of the K-ras oncogene in lung tumors. Cancer Res 2004; 64: 3096-3102.
83. Elchuri S, et al: CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005; 24: 367-380.
84. Phillips JP, et al: Null mutation of copper/zinc superoxide dismutase in Drosophila confers hypersensitivity to paraquat and reduced longevity. Proc Natl Acad Sci USA 1989; 86: 2761-2765.
85. Velarde MC, et al: Mitochondrial oxidative stress caused by Sod2 deficiency promotes cellular senescence and aging phenotypes in the skin. Aging (Albany NY) 2012; 4: 3-12.
86. Melov S, et al: Extension of life-span with superoxide dismutase/catalase mimetics. Science 2000; 289: 1567-1569.
87. Gruber J, et al: Mitochondria-targeted antioxidants and metabolic modulators as pharmacological interventions to slow ageing. Biotechnol Adv 2013; 31: 563-592.
88. Orr WC, Sohal RS: Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster . Science 1994; 263: 1128-1130.
89. Schriner SE, et al: Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005; 308: 1909-1911.
90. Lee HY, et al: Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab 2010; 12: 668-674.
91. Dai DF, et al: Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria. Aging Cell 2010; 9: 536-544.
92. Bevilacqua L, et al: Effects of short-and mediumterm calorie restriction on muscle mitochondrial proton leak and reactive oxygen species production. Am J Physiol Endocrinol Metab 2004; 286: E852-E861.
93. Gredilla R, et al: Caloric restriction decreases mitochondrial free radical generation at complex I and lowers oxidative damage to mitochondrial DNA in the rat heart. FASEB J 2001; 15: 1589-1591.
94. Sanz A, Caro P, Barja G: Protein restriction without strong caloric restriction decreases mitochondrial oxygen radical production and oxidative DNA damage in rat liver. J Bioenerg Biomembr 2004; 36: 545-552.
95. Migliaccio E, et al: The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999; 402: 309-313.
96. Giorgio M, et al: Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005; 122: 221-233.
97. Nemoto S, Finkel T: Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 2002; 295: 2450-2452.
98. Purdom S, Chen QM: Linking oxidative stress and genetics of aging with p66Shc signaling and forkhead transcription factors. Biogerontology 2003; 4: 181-191.
99. Lebiedzinska M, et al: Oxidative stress-dependent p66Shc phosphorylation in skin fibroblasts of children with mitochondrial disorders. Biochim Biophys Acta 2010; 1797: 952-960.
100. Lombard DB, et al: Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol 2007; 27: 8807-8814.
101. Qiu X, et al: Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 2010; 12: 662-667.
102. Tao R, et al: Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell 2010; 40: 893-904.
103. Jing E, et al: Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proc Natl Acad Sci USA 2011; 108: 14608-14613.
104. Someya S, et al: Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010; 143: 802-812.
105. Fernandez-Marcos PJ, Auwerx J: Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr 2011; 93: 884S-890S.
106. Rera M, et al: Modulation of longevity and tissue homeostasis by the Drosophila PGC-1 homolog. Cell Metab 2011; 14: 623-634.
107. Rossi DJ, Jamieson CH, Weissman IL: Stems cells and the pathways to aging and cancer. Cell 2008; 132: 681-696.
108. Rando TA: Stem cells, ageing and the quest for immortality. Nature 2006; 441: 1080-1086.
109. Urao N, Ushio-Fukai M: Redox regulation of stem/ progenitor cells and bone marrow iche. Free Radic Biol Med 2013; 54: 26-39.
110. Yahata T, et al: Accumulation of oxidative DNA damage restricts the self-renewal capacity of human hematopoietic stem cells. Blood 2011; 118: 2941-2950.
111. Ramalho-Santos J, et al: Mitochondrial functionality in reproduction: from gonads and gametes to embryos and embryonic stem cells. Hum Reprod Update 2009; 15: 553-572.
112. Hou Y, et al: Mitochondrial superoxide production negatively regulates neural progenitor proliferation and cerebral cortical development. Stem Cells 2012; 30: 2535-2547.
113. Lee Y, et al: Selective impairment on the proliferation of neural progenitor cells by oxidative phosphorylation disruption. Neurosci Lett 2013; 535: 134-139.
114. Chen CT, et al: Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 2008; 26: 960-968.
115. Bai X, et al: Ketamine enhances human neural stem cell proliferation and induces neuronal apoptosis via reactive oxygen species-mediated mitochondrial pathway. Anesth Analg 2013; 116: 869-880.
116. Berniakovich I, Laricchia-Robbio L, Izpisua Belmonte JC: N-acetylcysteine protects induced pluripotent stem cells from in vitro stress: impact on differentiation outcome. Int J Dev Biol 2012; 56: 729-735.
117. Madhavan L, Ourednik V, Ourednik J: Increased 'vigilance' of antioxidant mechanisms in neural stem cells potentiates their capability to resist oxidative stress. Stem Cells 2006; 24: 2110-2119.
118. Jang YY, Sharkis SJ: A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 2007; 110: 3056-3063.
119. Romero-Moya D, et al: Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function. Haematologica 2013; 98: 1022-1029.
120. Siggins RW, et al: Stem cells, phenotypic inversion, and differentiation. Int J Clin Exp Med 2008; 1: 2-21.
121. Cho YM, et al: Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochem Biophys Res Commun 2006; 348: 1472-1478.
122. Oh SK, et al: Derivation and characterization of new human embryonic stem cell lines: SNUhES1, SNUhES2, and SNUhES3. Stem Cells 2005; 23: 211-219.
123. St John JC, Jokhi RP, Barratt CL: The impact of mitochondrial genetics on male infertility. Int J Androl 2005; 28: 65-73.
124. St John JC, et al: The expression of mitochondrial DNA transcription factors during early cardiomyocyte in vitro differentiation from human embryonic stem cells. Cloning Stem Cells 2005; 7: 141-153.
125. Chung S, et al: Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med 2007; 4(suppl 1):S60-S67.
126. Saretzki G, et al: Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells. Stem Cells 2008; 26: 455-464.
127. Piccoli C, et al: Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells. Novel evidence of the occurrence of NAD(P)H oxidase activity. J Biol Chem 2005; 280: 26467-26476.
128. Ito K, et al: Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004; 431: 997-1002.
129. Nitta E, et al: Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a telomere-independent mechanism. Blood 2011; 117: 4169-4180.
130. Yalcin S, et al: ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3 -/- mice. EMBO J 2010; 29: 4118-4131.
131. Tothova Z, et al: FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007; 128: 325-339.
132. Mantel C, et al: Mouse hematopoietic cell-targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging-like phenotype. Blood 2012; 120: 2589-2599.
133. Liu F, Guan JL: FIP200, an essential component of mammalian autophagy is indispensible for fetal hematopoiesis. Autophagy 2011; 7: 229-230.
134. Wang C, et al: FIP200 is required for maintenance and differentiation of postnatal neural stem cells. Nat Neurosci 2013; 16: 532-542.
135. George SK, et al: Mitochondrial peptidase IMMP2L mutation causes early onset of age-associated disorders and impairs adult stem cell self-renewal. Aging Cell 2011; 10: 584-594.
136. Chen C, et al: TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 2008; 205: 2397-2408.
137. Chen C, et al: The axis of mTOR-mitochondria- ROS and stemness of the hematopoietic stem cells. Cell Cycle 2009; 8: 1158-1160.
138. Iglesias-Bartolome R, et al: mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell 2012; 11: 401-414.
139. Mateos J, et al: Lamin A deregulation in human mesenchymal stem cells promotes an impairment in their chondrogenic potential and imbalance in their response to oxidative stress. Stem Cell Res 2013; 11: 1137-1148.
140. Jiang XY, et al: PGC-1alpha prevents apoptosis in adipose-derived stem cells by reducing reactive oxygen species production in a diabetic microenvironment. Diabetes Res Clin Pract 2013; 100: 368-375.
141. Urao N, et al: NADPH oxidase2 regulates bone marrow microenvironment following hindlimb ischemia: role in reparative mobilization of progenitor cells. Stem Cells 2012; 30: 923-934.
142. Takubo K, et al: Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 2010; 7: 391-402.
143. Rossi DJ, et al: Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle 2007; 6: 2371-2376.
144. Rossi DJ, et al: Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007; 447: 725-729.
145. Ahlqvist KJ, et al: Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice. Cell Metab 2012; 15: 100-109.
146. Hayflick L, Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25: 585-621.
147. Campisi J: Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120: 513-522.
148. Hayflick L: The cell biology of human aging. N Engl J Med 1976; 295: 1302-1308.
149. Sharpless NE, DePinho RA: Telomeres, stem cells, senescence, and cancer. J Clin Invest 2004; 113: 160-168.
150. Passos JF, Saretzki G, von Zglinicki T: DNA damage in telomeres and mitochondria during cellular senescence: is there a connection? Nucleic Acids Res 2007; 35: 7505-7513.
151. Ngo JK, Pomatto LC, Davies KJ: Upregulation of the mitochondrial Lon Protease allows adaptation to acute oxidative stress but dysregulation is associated with chronic stress, disease, and aging. Redox Biol 2013; 1: 258-264.
152. Lee MK, Hande MP, Sabapathy K: Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis. J Cell Sci 2005; 118: 819-829.
153. Kondoh H, et al: Glycolytic enzymes can modulate cellular life span. Cancer Res 2005; 65: 177-185.
154. Chen Q, et al: Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci USA 1995; 92: 4337-4341.
155. Serra V, et al: Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem 2003; 278: 6824-6830.
156. Lu T, Finkel T: Free radicals and senescence. Exp Cell Res 2008; 314: 1918-1922.
157. Parrinello S, et al: Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 2003; 5: 741-747.
158. von Zglinicki T, et al: Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 1995; 220: 186-193.
159. Bodnar AG, et al: Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 349-352.
160. Richter T, von Zglinicki T: A continuous correlation between oxidative stress and telomere shortening in fibroblasts. Exp Gerontol 2007; 42: 1039-1042.
161. Liu L, et al: Mitochondrial dysfunction leads to telomere attrition and genomic instability. Aging Cell 2002; 1: 40-46.
162. Saretzki G, Murphy MP, von Zglinicki T: MitoQ counteracts telomere shortening and elongates lifespan of fibroblasts under mild oxidative stress. Aging Cell 2003; 2: 141-143.
163. Szalai VA, Singer MJ, Thorp HH: Site-specific probing of oxidative reactivity and telomerase function using 7,8-dihydro-8-oxoguanine in telomeric DNA. J Am Chem Soc 2002; 124: 1625-1631.
164. Opresko PL, et al: Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2. Nucleic Acids Res 2005; 33: 1230-1239.
165. Palm W, de Lange: How shelterin protects mammalian telomeres. Annu Rev Genet 2008; 42: 301-334.
166. Haendeler J, et al: Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res 2004; 94: 768-775.
167. Achanta G, Huang P: Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents. Cancer Res 2004; 64: 6233-6239.
168. Fujita K, et al: Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence. Nat Cell Biol 2010; 12: 1205-1212.
169. Serrano M, et al: Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88: 593-601412.
170. Moiseeva O, et al: Mitochondrial dysfunction contributes to oncogene-induced senescence. Mol Cell Biol 2009; 29: 4495-4507.
171. Zhang Y, Herman B: Ageing and apoptosis. Mech Ageing Dev 2002; 123: 245-260.
172. Marchi S, et al: Mitochondria-ROS crosstalk in the control of cell death and aging. J Signal Transduct 2012; 2012: 329635.
173. Klionsky DJ, Emr SD: Autophagy as a regulated pathway of cellular degradation. Science 2000; 290: 1717-1721.
174. Decuypere JP, et al: IP Receptors, mitochondria, and Ca signaling: implications for aging. J Aging Res 2011; 2011: 920178.
175. Bjedov I, et al: Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster . Cell Metab 2010; 11: 35-46.
176. Blagosklonny MV: Rapamycin-induced glucose intolerance: hunger or starvation diabetes. Cell Cycle 2011; 10: 4217-4224.
177. Harrison DE, et al: Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009; 460: 392-395.
178. Rubinsztein DC, Marino G, Kroemer G: Autophagy and aging. Cell 2011; 146: 682-695.
179. Zhang C, Cuervo AM: Restoration of chaperonemediated autophagy in aging liver improves cellular maintenance and hepatic function. Nat Med 2008; 14: 959-965.
180. Wenk GL: Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 2003; 64(suppl 9):7-10.
181. Blass JP, Gibson GE: The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Rev Neurol (Paris) 1991; 147: 513-525.
182. Blass JP, et al: Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. Arch Neurol 1990; 47: 864-869.
183. Hirai K, et al: Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 2001; 21: 3017-3023.
184. Kish SJ, et al: Brain cytochrome oxidase in Alzheimer's disease. J Neurochem 1992; 59: 776-779.
185. Lovell MA, Markesbery WR: Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res 2007; 85: 3036-3040.
186. Huang X, et al: Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann NY Acad Sci 2004; 1012: 153-163.
187. Leuner K, et al: Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid Redox Signal 2012; 16: 1421-1433.
188. Smith RA, Murphy MP: Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann NY Acad Sci 2010; 1201: 96-103.
189. Wadsworth TL, et al: Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease. J Alzheimers Dis 2008; 14: 225-234.
190. Anandatheerthavarada HK, et al: Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 2003; 161: 41-54.
191. Resende R, et al: Brain oxidative stress in a tripletransgenic mouse model of Alzheimer disease. Free Radic Biol Med 2008; 44: 2051-2057.
192. Sonnen JA, et al: Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radic Biol Med 2008; 45: 219-230.
193. Dumont M, Beal MF: Neuroprotective strategies involving ROS in Alzheimer disease. Free Radic Biol Med 2011; 51: 1014-1026.
194. Cardoso SM, et al: Cytochrome c oxidase is decreased in Alzheimer's disease platelets. Neurobiol Aging 2004; 25: 105-110.
195. Casley CS, et al: Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J Neurochem 2002; 80: 91-100.
196. Fukui, H, et al: Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2007; 104: 14163- 14168.
197. Mutisya EM, Bowling AC, Beal MF: Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem 1994; 63: 2179-2184.
198. Melov S, et al: Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS One 2007; 2:e536.
199. Manczak M, Calkins MJ, Reddy PH: Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Human molecular genetics 2011; 20: 2495-2509.
200. Wang X, et al: Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci USA 2008; 105: 19318- 19323.
201. Moreira PI, et al: Autophagocytosis of mitochondria is prominent in Alzheimer disease. J Neuropathol Exp Neurol 2007; 66: 525-532.
202. Wood-Kaczmar A, Gandhi S, Wood NW: Understanding the molecular causes of Parkinson's disease. Trends Mol Med 2006; 12: 521-528.
203. Langston J, et al: Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219: 979-980.
204. Mann VM, et al: Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann Neurol 1994; 36: 876-881.
205. Langston JW, et al: Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine exposure. Ann Neurol 1999; 46: 598-605.
206. Dauer W, Przedborski S: Parkinson's disease: mechanisms and models. Neuron 2003; 39: 889- 909.
207. Schapira AH: Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 2008; 7: 97-109.
208. Song DD, et al: Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 2004; 186: 158-172.
209. Martin LJ, et al: Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 2006; 26: 41-50.
210. Chinta SJ, et al: Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett 2010; 486: 235-239.
211. Flower TR, et al: Heat shock prevents alpha-synuclein- induced apoptosis in a yeast model of Parkinson's disease. J Mol Biol 2005; 351: 1081-1100.
212. Battisti C, et al: Oxidative-stress-induced apoptosis in PBLs of two patients with Parkinson disease secondary to alpha-synuclein mutation. J Neurol Sci 2008; 267: 120-124.
213. Kamp F, et al: Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J 2010; 29: 3571-3589.
214. Xie W, Chung KK: Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease. J Neurochem 2012; 122: 404-414.
215. Kitada T, et al: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605-608.
216. Rogaeva E, et al: Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch Neurol 2004; 61: 1898-1904.
217. Valente EM, et al: Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004; 304: 1158-1160.
218. Yang Y, et al: Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci USA 2006; 103: 10793-10798.
219. Park J, et al: Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 2006; 441: 1157-1161.
220. Clark IE, et al: Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 2006; 441: 1162-1166.
221. Exner N, et al: Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 2007; 27: 12413-12418.
222. Deng H, et al: The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila . Proc Natl Acad Sci USA 2008; 105: 14503-14508.
223. Yu W, et al: The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons. Hum Mol Genet 2011; 20: 3227-3240.
224. Siddiqui A, Hanson I, Andersen JK: Mao-B elevation decreases parkin's ability to efficiently clear damaged mitochondria: protective effects of rapamycin. Free Radic Res 2012; 46: 1011-1018.
225. Kuroda Y, et al: Parkin enhances mitochondrial biogenesis in proliferating cells. Hum Mol Genet 2006; 15: 883-895.
226. Bonifati V, et al: DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 2003; 24: 159-160.
227. Taira T, et al: DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 2004; 5: 213-218.
228. Clements CM, et al: DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA 2006; 103: 15091-15096.
229. Irrcher I, et al: Loss of the Parkinson's diseaselinked gene DJ-1 perturbs mitochondrial dynamics. Hum Mol Genet 2010; 19: 3734-3746.
230. Goldberg MS, et al: Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 2005; 45: 489-496.
231. Kim RH, et al: Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci USA 2005; 102: 5215-5220.
232. Paterna JC, et al: DJ-1 and Parkin modulate dopamine- dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol Ther 2007; 15: 698-704.
233. Krebiehl G, et al: Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1. PLoS One 2010; 5:e9367.
234. Wang X, et al: Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction. J Neurochem 2012; 121: 830-839.
235. Guo L, Wang W, Chen SG: Leucine-rich repeat kinase 2: relevance to Parkinson's disease. Int J Biochem Cell Biol 2006; 38: 1469-1475.
236. Niu J, et al: Leucine-rich repeat kinase2 disturbs mitochondrial dynamics via Dynamin-like protein. J Neurochem 2012; 122: 650-658.
237. Wang X, et al: LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet 2012; 21: 1931-1944.
238. MacDonald ME, et al: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971-983.
239. Bossy-Wetzel E, Petrilli A, Knott AB: Mutant huntingtin and mitochondrial dysfunction. Trends Neurosci 2008; 31: 609-616.
240. Orr AL, et al: N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 2008; 28: 2783-2792.
241. Squitieri F, et al: Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation. Mech Ageing Dev 2006; 127: 217-220.
242. Panov AV, et al: Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci 2002; 5: 731-736.
243. Choo YS, et al: Mutant huntingtin directly increases susceptibility of mitochondria to the calciuminduced permeability transition and cytochrome c release. Human molecular genetics 2004; 13: 1407- 1420.
244. Gizatullina ZZ, et al: Low stability of Huntington muscle mitochondria against Ca 2+ in R6/2 mice. Ann Neurol 2006; 59: 407-411.
245. Steffan JS, et al: The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci USA 2000; 97: 6763-6768.
246. Lin J, et al: Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 2004; 119: 121-135.
247. Cozzolino M, Carri MT: Mitochondrial dysfunction in ALS. Prog Neurobiol 2012; 97: 54-66.
248. Calabrese V, et al: Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J Neurol Sci 2005; 233: 145-162.
249. Atorino L, et al: Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J Cell Biol 2003; 163: 777-787.
250. Wallace DC: Mitochondria and cancer: Warburg addressed. Cold Spring Harb Symp Quant Biol 2005; 70: 363-374.
251. Ballinger SW: Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 2005; 38: 1278-1295.
252. Supale S, et al: Mitochondrial dysfunction in pancreatic beta cells. Trends Endocrinol Metab 2012; 23: 477-487.
253. Blanco FJ, Rego I, Ruiz-Romero C: The role of mitochondria in osteoarthritis. Nat Rev Rheumatol 2011; 7: 161-169.
254. Hiona A, Leeuwenburgh C: The role of mitochondrial DNA mutations in aging and sarcopenia: implications for the mitochondrial vicious cycle theory of aging. Exp Gerontol 2008; 43: 24-33.
255. Andziak B, et al: High oxidative damage levels in the longest-living rodent, the naked mole-rat. Aging Cell 2006; 5: 463-471.
256. Schulz TJ, et al: Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab 2007; 6: 280-293.
257. Sharma PK, Agrawal V, Roy N: Mitochondria-mediated hormetic response in life span extension of calorie-restricted Saccharomyces cerevisiae . Age (Dordr) 2010; 33: 143-154.
258. Zuin A, et al: Lifespan extension by calorie restriction relies on the Sty1 MAP kinase stress pathway. EMBO J 2010; 29: 981-991.
259. Lin SJ, et al: Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature 2002; 418: 344-348.
260. Perez VI, et al: The overexpression of major antioxidant enzymes does not extend the lifespan of mice. Aging Cell 2009; 8: 73-75.
261. Tyynismaa H, et al: Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice. Proc Natl Acad Sci USA 2005; 102: 17687-17692.
262. Sena LA, Chandel NS: Physiological roles of mitochondrial reactive oxygen species. Mol Cell 2012; 48: 158-167.
263. Hekimi S, Lapointe J, Wen Y: Taking a 'good' look at free radicals in the aging process. Trends Cell Biol 2011; 21: 569-576.
264. Ewbank JJ, et al: Structural and functional conservation of the Caenorhabditis elegans timing gene clk-1. Science 1997; 275: 980-983.
265. Lapointe J, et al: Reversal of the mitochondrial phenotype and slow development of oxidative biomarkers of aging in long-lived Mclk1+/- mice. J Biol Chem 2009; 284: 20364-20374.
266. Yang W, Hekimi S: A mitochondrial superoxide signal triggers increased longevity in Caenorhabditis elegans . PLoS Biol 2010; 8:e1000556.